(Q35583151)

9 August 2017

1 reference

title

Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum (English)

1 reference

9 August 2017

U R Hengge

1

1 reference

9 August 2017

M Cusini

series ordinal

2

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

British Journal of Dermatology

9 August 2017

published in

1 reference

9 August 2017

volume

149 Suppl 66

1 reference

9 August 2017

page(s)

15-19

1 reference

Immunological events in regressing genital warts

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Antiviral therapy for human papillomaviruses: rational and prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Topical immunomodulators--progress towards treating inflammation, infection, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Application of imiquimod by suppositories (anal tampons) efficiently prevents recurrences after ablation of anal canal condyloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Dermal dendritic cells in anogenital warty lesions unresponsive to an immune-response modifier

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Efficacy of imiquimod on external anogenital warts in HIV-infected patients previously treated by highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Natural history of warts. A two-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Decline of infectious skin manifestations in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

Potentiating effect of imiquimod in the treatment of verrucae vulgares in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0366-077X.2003.05623.X

10.1046/J.0366-077X.2003.05623.X

21 January 2018

Identifiers

DOI

1 reference

release_4zduhmhfufhv5aogvzyzmw64wy

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4zduhmhfufhv5aogvzyzmw64wy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference